Three Japanese organizations are working together in order to search for a cure to alopecia, more commonly known hair loss. Kyocera Corp., Organ Technologies Inc. and research firm Riken have teamed up to develop a treatment that will regenerate hair follicles and promote hair growth which they aim to be commercially available by 2020.
According to Japan Times, a team from Riken have already made a regeneration treatment model for hair follicles and the three firms will be developing this existing model. Under the model, hair tissues were reportedly taken from a patient's scalp and two different cells were cultivated from these. Regenerated hair follicles from the cells were grafted back into thinning hair of patients.
Partnership to tackle vexing problem of treating hair loss https://t.co/jzSOwG7RAy
— The Japan Times (@japantimes) July 13, 2016
Riken has already been successful in regenerating body parts in mice such as hair follicles, teeth and certain glands, Forbes reports. The research firm reportedly uses the primordium method to achieve regeneration of body parts, involving the use of stem cells that are capable of becoming a number of different cells in the body.
Forbes added that the three Japanese firms are not the first to look at regeneration to treat hair loss, as the Sanford-Burham Medical Research Institute in California had announced using similar methods earlier this year. Even Japan cosmetic maker Shiseido has teamed up with Canada's RepliCel Life and Sciences on a regeneration method, with the goal of introducing a treatement by 2018 for a $1,000 cost.
At present, the most common treatments for hair loss are the use of hair growth tonic and hair transplants, reported Nature World News. Still, the report said that there are around 18 million people in Japan who are living with hair loss and in the United States, the people who are experiencing hair loss are three times greater in number, the majority of whom are males.
